Psychotic Disorders
📧 Sign up to get email alerts when something new happens for Psychotic Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Examining Strategy Monitoring and Remediation Training [NA]
Clinical trial update from the University of Toronto on study NCT04756388 examining strategy monitoring and remediation training; the trial …
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Virtual Cognitive Behavioural Therapy for Psychosis [NA]
This ClinicalTrials.gov entry notes a completed study evaluating virtual cognitive behavioural therapy for psychosis in individuals with psy…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Reducing Stigma Among Healthcare Providers (RESHAPE-cRCT) [NA]
A completed randomized controlled trial (RESHAPE-cRCT) sponsored by George Washington University evaluating a program to reduce stigma among…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Cannabinoids, Learning, and Memory [Phase 1]
Phase 1 clinical trial update from Yale University assessing cannabinoids' effects on learning and memory; the study involves cannabis-relat…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Cultural Adaptation of Group CBT Psychosis Manual and Establishing Its Efficacy in Pakistan [NA]
This entry reports a completed clinical trial evaluating a culturally adapted group cognitive behavioral therapy for psychosis and its effic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Toward a Computationally-Informed, Personalized Treatment for Hallucinations [EARLY_Phase 1]
An early-phase 1 study from Yale University is investigating a computationally-informed, personalized treatment for auditory hallucinations …
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis
This completed multicenter prospective cohort study examined the incidence of problem gambling and identified risk factors among young adult…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: DIALOG: Understanding Disorganisation: A Language-focused Global Initiative in Psychosis
This entry describes the DIALOG study, a language-focused global initiative in psychosis led by Douglas Mental Health University Institute. …
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial [NA]
The Vega Trial, investigating gym-based exercise training for young adults taking antipsychotic medications, is currently active but not rec…
-
CLINICAL_TRIALS guidance · 2025-04-02Clinical Trial Update: Implementation of National Guidelines for Treatment of Psychoses
This update reports the completion of a study evaluating the implementation of national guidelines for treating psychoses at University Hosp…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Impact of VVV Group for Veterans With SMI [NA]
A VA-sponsored clinical trial evaluating the VVV Group for veterans with serious mental illness has completed.
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Computer-assisted Risk Evaluation in the Early Detection of Psychotic Disorders [NA]
The document reports an ongoing clinical trial on computer-assisted risk evaluation for early detection and prevention of psychotic disorder…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Yoga-based Group Intervention (YoGI) for In-patients With Schizophrenia Spectrum Disorders [NA]
A clinical trial update noting ongoing recruitment for YoGI, a yoga-based group intervention for in-patients with schizophrenia spectrum and…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial [NA]
A randomized placebo-controlled trial is evaluating whether melatonin can improve schizophrenic symptoms in patients with schizophrenia or r…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Sensory Profile and Early Clinical Signs of Calm Room Users
This clinical trial update indicates a study on sensory profiles and early clinical signs among Calm Room users is currently recruiting.
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Innogenix, Inc.)
FDA approved a supplemental application for HALOPERIDOL submitted by Innogenix, Inc., marking an approved update to the product through a su…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for fluphenazine hydrochloride from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Investigation of Objective Cognitive Effort in Neuropsychological Evaluation of Psychotic Disorders
A clinical trial sponsored by University Hospital, Montpellier is investigating objective cognitive effort during neuropsychological evaluat…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Weight Management Program for Patients With First Episode Psychosis [Phase 1]
Phase 1 trial evaluating a weight management program for patients with first-episode psychosis has completed, with results posted January 14…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Psychosis Screening in Juvenile Justice [NA]
A completed clinical trial from Brown University on psychosis screening in juveniles within the justice system; results were posted on 2024-…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices [NA]
A recruiting clinical trial comparing avatar-mediated therapy with cognitive behavioral therapy for persistent hearing voices, sponsored by …
-
FDA approval · 2024-10-04FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Piramal Critical Care Inc.)
FDA approved a generic chlorpromazine hydrochloride product (Original Application) from Piramal Critical Care Inc.
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Semantic and Syntactic Computerized Analysis of Free Speech
A clinical trial is evaluating computerized semantic and syntactic analysis of free speech to study psychotic disorders, including schizophr…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Youth Experiences and Health Study
Clinical trial update for the Youth Experiences and Health Study (NCT03332966) led by the Finnish Institute for Health and Welfare; the stud…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Enhancing Psychiatric Nursing Skills in Auditory Hallucination Assessment Via AR/VR and Virtual OSCE [NA]
A randomized controlled trial protocol evaluating AR/VR and virtual OSCE-based training to improve psychiatric nurses' assessment of auditor…